Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Corominas, Júlia, Garriga, Carme, Prenafeta, Antoni, Moros, Alexandra, Cañete, Manuel, Barreiro, Antonio, González-González, Luis, Madrenas, Laia, Güell, Irina, Clotet, Bonaventura, Izquierdo-Useros, Nuria, Raïch-Regué, Dàlia, Gallemí, Marçal, Blanco, Julià, Pradenas, Edwards, Trinité, Benjamin, Prado, Julia G., Blanch-Lombarte, Oscar, Pérez-Caballero, Raúl, Plana, Montserrat, Esteban, Ignasi, Pastor-Quiñones, Carmen, Núñez-Costa, Xavier, Taleb, Rachel Abu, McSkimming, Paula, Soriano, Alex, Nava, Jocelyn, Anagua, Jesse Omar, Ramos, Rafel, Lluch, Ruth Martí, Comes, Aida Corpes, Romero, Susana Otero, Gomez, Xavier Martinez, Sans-Pola, Carla, Moltó, José, Benet, Susana, Bailón, Lucía, Arribas, Jose R., Borobia, Alberto M., Parada, Javier Queiruga, Navarro-Pérez, Jorge, Forner Giner, Maria José, Lucas, Rafael Ortí, Jiménez, María del Mar Vázquez, Compán, Salvador Oña, Alvarez-Mon, Melchor, Troncoso, Daniel, Arana-Arri, Eunate, Meijide, Susana, Imaz-Ayo, Natale, García, Patricia Muñoz, de la Villa Martínez, Sofía, Fernández, Sara Rodríguez, Prat, Teresa, Torroella, Èlia, Ferrer, Laura
Published in The Lancet regional health. Europe (01.05.2023)
Published in The Lancet regional health. Europe (01.05.2023)
Get full text
Journal Article